Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model
Sara Silva-Santos, … , Steven A. Kushner, Ype Elgersma
Sara Silva-Santos, … , Steven A. Kushner, Ype Elgersma
Published April 13, 2015
Citation Information: J Clin Invest. 2015;125(5):2069-2076. https://doi.org/10.1172/JCI80554.
View: Text | PDF
Research Article Genetics Article has an altmetric score of 29

Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model

  • Text
  • PDF
Abstract

Angelman syndrome (AS) is a severe neurodevelopmental disorder that results from loss of function of the maternal ubiquitin protein ligase E3A (UBE3A) allele. Due to neuron-specific imprinting, the paternal UBE3A copy is silenced. Previous studies in murine models have demonstrated that strategies to activate the paternal Ube3a allele are feasible; however, a recent study showed that pharmacological Ube3a gene reactivation in adulthood failed to rescue the majority of neurocognitive phenotypes in a murine AS model. Here, we performed a systematic study to investigate the possibility that neurocognitive rescue can be achieved by reinstating Ube3a during earlier neurodevelopmental windows. We developed an AS model that allows for temporally controlled Cre-dependent induction of the maternal Ube3a allele and determined that there are distinct neurodevelopmental windows during which Ube3a restoration can rescue AS-relevant phenotypes. Motor deficits were rescued by Ube3a reinstatement in adolescent mice, whereas anxiety, repetitive behavior, and epilepsy were only rescued when Ube3a was reinstated during early development. In contrast, hippocampal synaptic plasticity could be restored at any age. Together, these findings suggest that Ube3a reinstatement early in development may be necessary to prevent or rescue most AS-associated phenotypes and should be considered in future clinical trial design.

Authors

Sara Silva-Santos, Geeske M. van Woerden, Caroline F. Bruinsma, Edwin Mientjes, Mehrnoush Aghadavoud Jolfaei, Ben Distel, Steven A. Kushner, Ype Elgersma

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 Total
Citations: 4 13 14 20 21 18 10 12 10 6 6 134
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (134)

Title and authors Publication Year
Ubiquitin-Proteasome-Mediated Protein Degradation and Disorders of the Central Nervous System
Hegde AN, Timm LE, Sivley CJ, Ramiyaramcharankarthic S, Lowrimore OJ, Hendrix BJ, Grozdanov TG, Anderson WJ
International Journal of Molecular Sciences 2025
Prenatal gene editing for neurodevelopmental diseases: Ethical considerations
Major RM, Juengst ET
American Journal of Human Genetics 2025
Unraveling the Roles of UBE3A in Neurodevelopment and Neurodegeneration
Yang X, Huang YW
International Journal of Molecular Sciences 2025
Loss of UBE3A impacts both neuronal and non-neuronal cells in human cerebral organoids
Estridge RC, Yagci ZB, Sen D, Johnson TJ, Kelkar GR, Ptacek TS, Simon JM, Keung AJ
Communications Biology 2025
Overcoming genetic and cellular complexity to study the pathophysiology of X-linked intellectual disabilities.
Martinez D, Jiang E, Zhou Z
Journal of Neurodevelopmental Disorders 2024
Hyperexcitability and translational phenotypes in a preclinical mouse model of SYNGAP1-Related Intellectual Disability
Fenton TA, Haouchine OY, Hallam EL, Smith EM, Jackson KC, Rahbarian D, Canales C, Adhikari A, Nord AS, Ben-Shalom R, Silverman JL
Research square 2024
Reduction of APOE accounts for neurobehavioral deficits in fetal alcohol spectrum disorders.
Hwang HM, Yamashita S, Matsumoto Y, Ito M, Edwards A, Sasaki J, Dutta DJ, Mohammad S, Yamashita C, Wetherill L, Schwantes-An TH, Abreu M, Mahnke AH, Mattson SN, Foroud T, Miranda RC, Chambers C, Torii M, Hashimoto-Torii K
Molecular Psychiatry 2024
Need of orthogonal approaches in neurological disease modeling in mouse
Bossini L, Sessa A
Frontiers in molecular neuroscience 2024
Prenatal delivery of a therapeutic antisense oligonucleotide achieves broad biodistribution in the brain and ameliorates Angelman syndrome phenotype in mice
Clarke MT, Remesal L, Lentz L, Tan DJ, Young D, Thapa S, Namuduri SR, Borges B, Kirn G, Valencia J, Lopez ME, Lui JH, Shiow LR, Dindot S, Villeda S, Sanders SJ, MacKenzie TC
Molecular Therapy 2024
Regional and cellular organization of the autism-associated protein UBE3A/E6AP and its antisense transcript in the brain of the developing rhesus monkey
Gonzalez Ramirez C, Salvador SG, Patel RK, Clark S, Miller NW, James LM, Ringelberg NW, Simon JM, Bennett J, Amaral DG, Burette AC, Philpot BD
Frontiers in neuroanatomy 2024
Ube3a unsilencer for the potential treatment of Angelman syndrome
Vihma H, Li K, Welton-Arndt A, Smith AL, Bettadapur KR, Gilmore RB, Gao E, Cotney JL, Huang HC, Collins JL, Chamberlain SJ, Lee HM, Aubé J, Philpot BD
Nature Communications 2024
(1)H-NMR-based metabolomics reveals metabolic alterations in early development of a mouse model of Angelman syndrome.
Gupta PK, Barak S, Feuermann Y, Goobes G, Kaphzan H
Molecular autism 2024
Genotype-phenotype correlation over time in Angelman syndrome: Researching 134 patients
Fujimoto M, Nakamura Y, Hosoki K, Iwaki T, Sato E, Ieda D, Hori I, Negishi Y, Hattori A, Shiraishi H, Saitoh S
Human Genetics and Genomics Advances 2024
Joining forces to develop individualized antisense oligonucleotides for patients with brain or eye diseases: the example of the Dutch Center for RNA Therapeutics
Aartsma-Rus A, Collin RW, Elgersma Y, Lauffer MC, van Roon-Mom W
Therapeutic Advances in Rare Disease 2024
Hyperexcitability and translational phenotypes in a preclinical mouse model of SYNGAP1-related intellectual disability
Fenton TA, Haouchine OY, Hallam EB, Smith EM, Jackson KC, Rahbarian D, Canales CP, Adhikari A, Nord AS, Ben-Shalom R, Silverman JL
Translational Psychiatry 2024
Early Intervention services in the era of genomic medicine: setting a research agenda.
MacDuffie KE, Cohn B, Appelbaum P, Brothers KB, Doherty D, Goldenberg AJ, Reynolds E, Smith HS, Wheeler A, Yu JH
Pediatric research 2024
Widespread Gene Editing in the Brain via In Utero Delivery of mRNA Using Acid-Degradable Lipid Nanoparticles
Gao K, Han H, Cranick MG, Zhao S, Xu S, Yin B, Song H, Hu Y, Clarke MT, Wang D, Wong JM, Zhao Z, Burgstone BW, Farmer DL, Murthy N, Wang A
ACS Nano 2024
Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome
Dongwon Lee, Wu Chen, Heet Kaku, Xinming Zhuo, Eugene Chao, Armand Soriano, Allen Kuncheria, Stephanie Flores, Joo Hyun Kim, Frank Rigo, Paymaan Jafar-nejad, Arthur Beaudet, Matthew Caudill, Mingshan Xue
eLife 2023
A high-fidelity RNA-targeting Cas13 restores paternal Ube3a expression and improves Angelman syndrome in mice
Jinhui Li, Zhixin Shen, Yajing Liu, Zixiang Yan, Yuanhua Liu, Xiang Lin, Junjie Tang, Ruimin Lv, Guannan Geng, Changyang Zhou, Hui Yang
Molecular Therapy 2023
Transcriptional reprogramming restores UBE3A brain-wide and rescues behavioral phenotypes in an Angelman syndrome mouse model
Henriette O'Geen, Ulrika Beitnere, Miranda Garcia, Anna Adhikari, David Cameron, Timothy Fenton, Nycole Copping, Peter Deng, Samantha Lock, Julian Halmai, Isaac Villegas, Jiajian Liu, Danhui Wang, Gregory Davis, Kyle Fink, Jill Silverman, David Segal
Molecular Therapy 2023
UBE3A expression during early postnatal brain development is required for proper maturation of the dorsomedial striatum
Diana Rotaru, Ilse Wallaard, Maud Vries, Julia Bie, Ype Elgersma
JCI Insight 2023
Loss of CAMK2G affects intrinsic and motor behavior but has minimal impact on cognitive behavior
Rigter PM, de Konink C, van Woerden GM
Frontiers in neuroscience 2023
Therapeutic strategies for autism: targeting three levels of the central dogma of molecular biology
Hong D, Iakoucheva LM
Translational Psychiatry 2023
Elevated ROS levels during the early development of Angelman syndrome alter the apoptotic capacity of the developing neural precursor cells.
Simchi L, Gupta PK, Feuermann Y, Kaphzan H
Molecular Psychiatry 2023
Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases
Chaudhary P, Proulx J, Park IW
Virus Research 2023
Novel epigenetic molecular therapies for imprinting disorders.
Wang SE, Jiang YH
Molecular Psychiatry 2023
Autism-linked UBE3A gain-of-function mutation causes interneuron and behavioral phenotypes when inherited maternally or paternally in mice
Xing L, Simon JM, Ptacek TS, Yi JJ, Loo L, Mao H, Wolter JM, McCoy ES, Paranjape SR, Taylor-Blake B, Zylka MJ
Cell Reports 2023
Hyperexcitability and translational phenotypes in a preclinical model of SYNGAP1 mutations
Silverman JL, Fenton T, Haouchine O, Hallam E, Smith E, Jackson K, Rahbarian D, Canales C, Adhikari A, Nord A, Ben-Shalom R
Research square 2023
Stem cell models of Angelman syndrome
Camões dos Santos J, Appleton C, Cazaux Mateus F, Covas R, Bekman EP, da Rocha ST
Frontiers in Cell and Developmental Biology 2023
Contextual fear memory impairment in Angelman syndrome model mice is associated with altered transcriptional responses
Su W, Liu Y, Lam A, Hao X, Baudry M, Bi X
Scientific Reports 2023
UBE3A: The Role in Autism Spectrum Disorders (ASDs) and a Potential Candidate for Biomarker Studies and Designing Therapeutic Strategies.
Roy B, Amemasor E, Hussain S, Castro K
2023
Rescue of behavioral and electrophysiological phenotypes in a Pitt-Hopkins syndrome mouse model by genetic restoration of Tcf4 expression
H Kim, E Gao, A Draper, N Berens, H Vihma, X Zhang, A Higashi-Howard, K Ritola, J Simon, A Kennedy, B Philpot
eLife 2022
Adult Camk2a gene reinstatement restores the learning and plasticity deficits of Camk2a knockout mice
Pomme Rigter, Ilse Wallaard, Mehrnoush Aghadavoud, Jenina Kingma, Laura Post, Minetta Elgersma, Ype Elgersma, Geeske Woerden
iScience 2022
Molecular and behavioral consequences of Ube3a gene overdosage in mice
A. Punt, Matthew Judson, Michael Sidorov, Naomi S Johnson, Sabine Belder, Dion den Hertog, Courtney R. Davis, Maximillian Feygin, Mehrnoush Aghadavoud, Wilfred IJcken, Ype Elgersma, Benjamin Philpot
JCI Insight 2022
An in vivo Cell-Based Delivery Platform for Zinc Finger Artificial Transcription Factors in Pre-clinical Animal Models
P Deng, J Halmai, U Beitnere, D Cameron, M Martinez, C Lee, J Waldo, K Thongphanh, A Adhikari, N Copping, S Petkova, R Lee, S Lock, M Palomares, H OGeen, J Carter, C Gonzalez, F Buchanan, J Anderson, F Fierro, J Nolta, A Tarantal, J Silverman, D Segal, K Fink
Frontiers in molecular neuroscience 2022
Sex‐dependent influence of postweaning environmental enrichment in Angelman syndrome model mice
J Cosgrove, L Kelly, E Kiffmeyer, A Kloth
Brain and Behavior 2022
A Critical Period for Development of Cerebellar-Mediated Autism-Relevant Social Behavior
J Gibson, C Howland, C Ren, C Howland, A Vernino, P Tsai
The Journal of neuroscience : the official journal of the Society for Neuroscience 2022
Paradoxical Hyperexcitability in Disorders of Neurodevelopment
M Antoine
Frontiers in molecular neuroscience 2022
AntimiR targeting of microRNA-134 reduces seizures in a mouse model of Angelman syndrome
A Campbell, G Morris, A Sanfeliu, J Augusto, E Langa, J Kesavan, N Nguyen, R Conroy, J Worm, L Kielpinski, M Jensen, M Miller, T Kremer, C Reschke, D Henshall
Molecular Therapy — Nucleic Acids 2022
A cross-species spatiotemporal proteomic analysis identifies UBE3A-dependent signaling pathways and targets
Pandya NJ, Meier S, Tyanova S, Terrigno M, Wang C, Punt AM, Mientjes EJ, Vautheny A, Distel B, Kremer T, Elgersma Y, Jagasia R
Molecular Psychiatry 2022
Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders
Davidson BL, Gao G, Berry-Kravis E, Bradbury AM, Bönnemann C, Buxbaum JD, Corcoran GR, Gray SJ, Gray-Edwards H, Kleiman RJ, Shaywitz AJ, Wang D, Zoghbi HY, Flotte TR, Tauscher-Wisniewski S, Tifft CJ, Sahin M
Molecular Therapy 2022
An Association Study of DNA Methylation and Gene Expression in Angelman Syndrome: A Bioinformatics Approach
Panov J, Kaphzan H
International journal of molecular sciences 2022
Reconsidering animal models used to study autism spectrum disorder: Current state and optimizing future
Silverman JL, Thurm A, Ethridge SB, Soller MM, Petkova SP, Abel T, Bauman MD, Brodkin ES, Harony-Nicolas H, Wöhr M, Halladay A
Genes, brain, and behavior 2022
Generation and Characterization of a Novel Angelman Syndrome Mouse Model with a Full Deletion of the Ube3a Gene
Syding LA, Kubik-Zahorodna A, Nickl P, Novosadova V, Kopkanova J, Kasparek P, Prochazka J, Sedlacek R
Cells 2022
Open the Window for the Cure of Dravet
Gu B
Epilepsy Currents 2022
Multidimensional analysis of behavior predicts genotype with high accuracy in a mouse model of Angelman syndrome
Tanas JK, Kerr DD, Wang L, Rai A, Wallaard I, Elgersma Y, Sidorov MS
Translational Psychiatry 2022
Behavioral and brain anatomical analysis of Foxg1 heterozygous mice
Erickson KR, Farmer R, Merritt JK, Miletic Lanaghan Z, Does MD, Ramadass K, Landman BA, Cutting LE, Neul JL
PloS one 2022
Promising therapeutic aspects in human genetic imprinting disorders
Chao Y, Qin Y, Zou X, Wang X, Hu C, Xia F, Zou C
Clinical Epigenetics 2022
Improving Gene Therapy for Angelman Syndrome with Secreted Human UBE3A
Nenninger AW, Willman M, Willman J, Stewart E, Mesidor P, Novoa M, Morrill NK, Alvarez L, Joly-Amado A, Peters MM, Gulick D, Nash KR
Neurotherapeutics 2022
Newborn screening for neurodevelopmental diseases: Are we there yet?
Chung WK, Berg JS, Botkin JR, Brenner SE, Brosco JP, Brothers KB, Currier RJ, Gaviglio A, Kowtoniuk WE, Olson C, Lloyd-Puryear M, Saarinen A, Sahin M, Shen Y, Sherr EH, Watson MS, Hu Z
American journal of medical genetics. Part C, Seminars in medical genetics 2022
The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome
Viho EM, Punt AM, Distel B, Houtman R, Kroon J, Elgersma Y, Meijer OC
International journal of molecular sciences 2022
CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice
Ralf S Schmid, Xuefeng Deng, Priyalakshmi Panikker, Msema Msackyi, Camilo Breton, James M. Wilson
Journal of Clinical Investigation 2021
TorsinA restoration in a mouse model identifies a critical therapeutic window for DYT1 dystonia
Jay Li, Daniel S. Levin, Audrey J Kim, Samuel S Pappas, William Dauer
Journal of Clinical Investigation 2021
Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman Syndrome mouse model
Claudia Milazzo, Edwin J. Mientjes, Ilse Wallaard, Søren Vestergaard Rasmussen, Kamille Dumong Erichsen, Tejaswini Kakunuri, A.S. Elise van der Sman, Thomas Kremer, Meghan.T. Miller, Marius C. Hoener, Ype Elgersma
JCI Insight 2021
Dual-isoform hUBE3A gene transfer improves behavioral and seizure outcomes in Angelman syndrome model mice
Matthew C. Judson, Charles Shyng, Jeremy M. Simon, Courtney R. Davis, A. Mattijs Punt, Mirabel Salmon, Noah W. Miller, Kimberly D. Ritola, Ype Elgersma, David G. Amaral, Steven J Gray, Benjamin D. Philpot
JCI Insight 2021
CNS critical periods: implications for dystonia and other neurodevelopmental disorders
Jay Li, Sumin Kim, Samuel S. Pappas, William Dauer
JCI Insight 2021
Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells
A Adhikari, NA Copping, J Beegle, DL Cameron, P Deng, H OGeen, DJ Segal, KD Fink, JL Silverman, JS Anderson
Human Molecular Genetics 2021
Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3am−/p+ Mice Modelling Angelman Syndrome Are Attenuated by Adenosine A2A Receptor Blockade
A Moreira-de-Sá, FQ Gonçalves, JP Lopes, HB Silva, ÂR Tomé, RA Cunha, PM Canas
Molecular Neurobiology 2021
UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
Y Elgersma, M Sonzogni
Developmental medicine and child neurology 2021
Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome
NA Copping, SM McTighe, KD Fink, JL Silverman
Neurotherapeutics 2021
Postnatal therapeutic approaches in genetic neurodevelopmental disorders
G Levy, B Barak
NEURAL REGEN RES 2021
Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice
GL Sell, W Xin, EK Cook, MA Zbinden, TB Schaffer, RN OMeally, RN Cole, SS Margolis
Scientific Reports 2021
Neural Correlates of Auditory Hypersensitivity in Fragile X Syndrome
KA Razak, DK Binder, IM Ethell
Frontiers in Psychiatry 2021
Electrophysiological Characterization of Regular and Burst Firing Pyramidal Neurons of the Dorsal Subiculum in an Angelman Syndrome Mouse Model
PR Rayi, H Kaphzan
Frontiers in cellular neuroscience 2021
Postnatal Arx transcriptional activity regulates functional properties of PV interneurons
DJ Joseph, MV Deimling, Y Hasegawa, AG Cristancho, RC Ahrens-Nicklas, SL Rogers, R Risbud, AJ McCoy, ED Marsh
iScience 2021
Epilepsy in Angelman syndrome: A scoping review
D Samanta
Brain & development 2021
Derepression of inflammation-related genes link to microglia activation and neural maturation defect in a mouse model of Kleefstra syndrome
A Yamada, T Hirasawa, K Nishimura, C Shimura, N Kogo, K Fukuda, M Kato, M Yokomori, T Hayashi, M Umeda, M Yoshimura, Y Iwakura, I Nikaido, S Itohara, Y Shinkai
iScience 2021
Pre-symptomatic intervention for autism spectrum disorder (ASD): defining a research agenda
R Grzadzinski, D Amso, R Landa, L Watson, M Guralnick, L Zwaigenbaum, G Deák, A Estes, J Brian, K Bath, J Elison, L Abbeduto, J Wolff, J Piven
Journal of Neurodevelopmental Disorders 2021
Predicting Autism in Infancy
JJ Wolff, J Piven
Journal of the American Academy of Child and Adolescent Psychiatry 2021
Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies?
JC Carpenter, G Lignani
Neurotherapeutics 2021
Insulin-like growth factor-2 does not improve behavioral deficits in mouse and rat models of Angelman Syndrome
EL Berg, SP Petkova, HA Born, A Adhikari, AE Anderson, JL Silverman
Molecular autism 2021
Genetic therapies for neurological disorders
L FitzPatrick, A Bird
Human Genetics 2021
CIM6P / IGF ‐2 Receptor Ligands Reverse Deficits in Angelman Syndrome Model Mice
E Cruz, G Descalzi, A Steinmetz, HE Scharfman, A Katzman, CM Alberini
Autism research : official journal of the International Society for Autism Research 2020
Chronic α1-Na/K-ATPase inhibition reverses the elongation of the axon initial segment of the hippocampal CA1 pyramidal neurons in Angelman syndrome model mice
PR Rayi, AY Bagrov, H Kaphzan
Neuropsychopharmacology 2020
Neurodevelopmental Disorders: Employing iPSC Technologies to Define and Treat Childhood Brain Diseases
E DiCicco-Bloom, JH Millonig
2020
CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review
LA Syding, P Nickl, P Kasparek, R Sedlacek
Cells 2020
Disrupted Functional and Structural Connectivity in Angelman Syndrome
HM Yoon, Y Jo, WH Shim, JS Lee, TS Ko, JH Koo, MS Yum
American Journal of Neuroradiology 2020
Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome
M Sonzogni, P Zhai, EJ Mientjes, GM van Woerden, Y Elgersma
Molecular autism 2020
Region and Cell Type Distribution of TCF4 in the Postnatal Mouse Brain
H Kim, NC Berens, NE Ochandarena, BD Philpot
Frontiers in neuroanatomy 2020
Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome
EL Berg, MC Pride, SP Petkova, RD Lee, NA Copping, Y Shen, A Adhikari, TA Fenton, LR Pedersen, LS Noakes, BJ Nieman, JP Lerch, S Harris, HA Born, MM Peters, P Deng, DL Cameron, KD Fink, U Beitnere, H OGeen, AE Anderson, SV Dindot, KR Nash, EJ Weeber, M Wöhr, J Ellegood, DJ Segal, JL Silverman
Translational Psychiatry 2020
Novel Insights into the Role of UBE3A in Regulating Apoptosis and Proliferation
L Simchi, J Panov, O Morsy, Y Feuermann, H Kaphzan
Journal of Clinical Medicine 2020
Molecular Evolution, Neurodevelopmental Roles and Clinical Significance of HECT-Type UBE3 E3 Ubiquitin Ligases
MC Ambrozkiewicz, KJ Cuthill, D Harnett, H Kawabe, V Tarabykin
Cells 2020
Behavioral Evaluation of Angelman Syndrome Mice at Older Ages
R Dutta, JN Crawley
Neuroscience 2020
Developmental studies in fragile X syndrome
KA Razak, KC Dominick, CA Erickson
Journal of Neurodevelopmental Disorders 2020
Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA
JM Wolter, H Mao, G Fragola, JM Simon, JL Krantz, HO Bazick, B Oztemiz, JL Stein, MJ Zylka
Nature 2020
Recent advances in gene therapy for neurodevelopmental disorders with epilepsy
TJ Turner, C Zourray, S Schorge, G Lignani
Journal of Neurochemistry 2020
Human Cerebral Organoids Reveal Early Spatiotemporal Dynamics and Pharmacological Responses of UBE3A
D Sen, A Voulgaropoulos, Z Drobna, AJ Keung
Stem Cell Reports 2020
Leveraging large genomic datasets to illuminate the pathobiology of autism spectrum disorders
VB Quick, B Wang, MW State
Neuropsychopharmacology 2020
Considerations for Clinical Therapeutic Development of Statins for Neurodevelopmental Disorders
MJ Ottenhoff, LC Krab, Y Elgersma
eNeuro 2020
Evaluation of a TrkB agonist on spatial and motor learning in the Ube3a mouse model of Angelman syndrome
MN Schultz, JN Crawley
Learning & memory (Cold Spring Harbor, N.Y.) 2020
Cannabidiol attenuates seizures and EEG abnormalities in Angelman syndrome model mice
Bin Gu, Manhua zhu, Madison Glass, Marie Rougié, Viktoriya D Nikolova, Sheryl S. Moy, Paul R. Carney, Benjamin D. Philpot
Journal of Clinical Investigation 2019
The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions
N Khatri, HY Man
Frontiers in molecular neuroscience 2019
Circadian biology and sleep in monogenic neurological disorders and its potential application in drug discovery
S Shi, CH Johnson
Current Opinion in Behavioral Sciences 2019
UBE3A: An E3 Ubiquitin Ligase With Genome-Wide Impact in Neurodevelopmental Disease
SJ Lopez, DJ Segal, JM LaSalle
Frontiers in molecular neuroscience 2019
UBE3A regulates the transcription of IRF, an antiviral immunity
R Furumai, K Tamada, X Liu, T Takumi
Human Molecular Genetics 2019
Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes
M Sonzogni, J Hakonen, MB Kleijn, S Silva-Santos, MC Judson, BD Philpot, GM van Woerden, Y Elgersma
Molecular autism 2019
The role of ubiquitin ligase E3A in polarized contact guidance and rescue strategies in UBE3A-deficient hippocampal neurons
I Tonazzini, GM Woerden, C Masciullo, EJ Mientjes, Y Elgersma, M Cecchini
Molecular autism 2019
Prenatal treatment path for angelman syndrome and other neurodevelopmental disorders
MJ Zylka
Autism research : official journal of the International Society for Autism Research 2019
Simvastatin Restores HDAC1/2 Activity and Improves Behavioral Deficits in Angelman Syndrome Model Mouse
V Kumar, T Joshi, N Vatsa, BK Singh, NR Jana
Frontiers in molecular neuroscience 2019
Apparent Genetic Rescue of Adult Shank3 Exon 21 Insertion Mutation Mice Tempered by Appropriate Control Experiments
HE Speed, M Kouser, Z Xuan, S Liu, A Duong, CM Powell
eNeuro 2019
Ube3a reinstatement mitigates epileptogenesis in Angelman syndrome model mice
Bin Gu, Kelly Carstens, Matthew Judson, Katherine Dalton, Marie Rougié, Ellen Clark, Serena M. Dudek, Benjamin D. Philpot
Journal of Clinical Investigation 2018
Autism spectrum disorder: prospects for treatment using gene therapy
M Benger, M Kinali, ND Mazarakis
Molecular autism 2018
A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders
AJ George, YC Hoffiz, AJ Charles, Y Zhu, AM Mabb
Frontiers in Genetics 2018
Hippocampal deficits in neurodevelopmental disorders
Y Li, M Shen, ME Stockton, X Zhao
Neurobiology of Learning and Memory 2018
Uncovering True Cellular Phenotypes: Using Induced Pluripotent Stem Cell-Derived Neurons to Study Early Insults in Neurodevelopmental Disorders
JJ Fink, ES Levine
Frontiers in neurology 2018
Enhanced Transmission at the Calyx of Held Synapse in a Mouse Model for Angelman Syndrome
T Wang, GM van Woerden, Y Elgersma, JG Borst
Frontiers in cellular neuroscience 2018
Taurine Administration Recovers Motor and Learning Deficits in an Angelman Syndrome Mouse Model
S Guzzetti, L Calzari, L Buccarello, V Cesari, I Toschi, S Cattaldo, A Mauro, F Pregnolato, S Mazzola, S Russo
International journal of molecular sciences 2018
Enhanced Operant Extinction and Prefrontal Excitability in a Mouse Model of Angelman Syndrome
MS Sidorov, MC Judson, H Kim, M Rougie, AI Ferrer, VD Nikolova, NV Riddick, SS Moy, BD Philpot
The Journal of neuroscience : the official journal of the Society for Neuroscience 2018
A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel Ube3a mutants
M Sonzogni, I Wallaard, SS Santos, J Kingma, D du Mee, GM van Woerden, Y Elgersma
Molecular autism 2018
Sensitive Periods for Cerebellar-Mediated Autistic-like Behaviors
PT Tsai, S Rudolph, C Guo, J Ellegood, JM Gibson, SM Schaeffer, J Mogavero, JP Lerch, W Regehr, M Sahin
Cell Reports 2018
Adult Ube3a Gene Reinstatement Restores the Electrophysiological Deficits of Prefrontal Cortex Layer 5 Neurons in a Mouse Model of Angelman Syndrome
DC Rotaru, GM van Woerden, I Wallaard, Y Elgersma
The Journal of neuroscience : the official journal of the Society for Neuroscience 2018
Epigenetic and Cellular Diversity in the Brain through Allele-Specific Effects
WC Huang, K Bennett, C Gregg
Trends in Neurosciences 2018
Mechanisms underlying cognitive deficits in a mouse model for Costello Syndrome are distinct from other RASopathy mouse models
J Schreiber, LA Grimbergen, I Overwater, T der Vaart, J Stedehouder, AJ Schuhmacher, C Guerra, SA Kushner, D Jaarsma, Y Elgersma
Scientific Reports 2017
Cellular and Circuitry Bases of Autism: Lessons Learned from the Temporospatial Manipulation of Autism Genes in the Brain
SW Hulbert, Y Jiang
Neuroscience Bulletin 2017
Early Origin and Evolution of the Angelman Syndrome Ubiquitin Ligase Gene Ube3a
M Sato
Frontiers in cellular neuroscience 2017
Proteomic Analysis After Status Epilepticus Identifies UCHL1 as Protective Against Hippocampal Injury
JP Reynolds, EM Jimenez-Mateos, L Cao, F Bian, M Alves, SF Miller-Delaney, A Zhou, DC Henshall
Neurochemical Research 2017
E3 Ubiquitin Ligases Neurobiological Mechanisms: Development to Degeneration
A Upadhyay, V Joshi, A Amanullah, R Mishra, N Arora, A Prasad, A Mishra
Frontiers in molecular neuroscience 2017
Maturation, Refinement, and Serotonergic Modulation of Cerebellar Cortical Circuits in Normal Development and in Murine Models of Autism
E Hoxha, P Lippiello, B Scelfo, F Tempia, M Ghirardi, MC Miniaci
Neural plasticity 2017
Ube3a loss increases excitability and blunts orientation tuning in the visual cortex of Angelman syndrome model mice
ML Wallace, GM van Woerden, Y Elgersma, SL Smith, BD Philpot
Journal of neurophysiology 2017
Enhanced Nociception in Angelman Syndrome Model Mice
ES McCoy, B Taylor-Blake, M Aita, JM Simon, BD Philpot, MJ Zylka
The Journal of neuroscience : the official journal of the Society for Neuroscience 2017
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
EM Berry-Kravis, L Lindemann, AE Jønch, G Apostol, MF Bear, RL Carpenter, JN Crawley, A Curie, VD Portes, F Hossain, F Gasparini, B Gomez-Mancilla, D Hessl, E Loth, SH Scharf, PP Wang, FV Raison, R Hagerman, W Spooren, S Jacquemont
Nature Reviews Drug Discovery 2017
The Autism Protein Ube3A/E6AP Remodels Neuronal Dendritic Arborization via Caspase-Dependent Microtubule Destabilization
N Khatri, JP Gilbert, Y Huo, R Sharaflari, M Nee, H Qiao, HY Man
The Journal of neuroscience : the official journal of the Society for Neuroscience 2017
New Perspectives on Genomic Imprinting, an Essential and Multifaceted Mode of Epigenetic Control in the Developing and Adult Brain
JD Perez, ND Rubinstein, C Dulac
Annual Review of Neuroscience 2016
Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links
SW Hulbert, YH Jiang
Neuroscience 2016
Angelman syndrome — insights into a rare neurogenetic disorder
K Buiting, C Williams, B Horsthemke
Nature Reviews Neurology 2016
Acute and crucial requirement for MeCP2 function upon transition from early to late adult stages of brain maturation
F Du, MV Nguyen, A Karten, CA Felice, G Mandel, N Ballas
Human Molecular Genetics 2016
GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility
MC Judson, ML Wallace, MS Sidorov, AC Burette, B Gu, GM van Woerden, IF King, JE Han, MJ Zylka, Y Elgersma, RJ Weinberg, BD Philpot
Neuron 2016
Dysfunctional cerebellar Purkinje cells contribute to autism-like behaviour in Shank2-deficient mice
S Peter, MM Brinke, J Stedehouder, CM Reinelt, B Wu, H Zhou, K Zhou, HJ Boele, SA Kushner, MG Lee, MJ Schmeisser, TM Boeckers, M Schonewille, FE Hoebeek, CI de Zeeuw
Nature Communications 2016
Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome model
Caroline Bruinsma, Martijn Schonewille, Zhenyu Gao, Eleonora Aronica, Matthew Judson, Benjamin D. Philpot, Freek Hoebeek, Geeske van Woerden, Chris I. De Zeeuw, Ype Elgersma
Journal of Clinical Investigation 2015
Potential therapeutic approaches for Angelman syndrome
X Bi, J Sun, AX Ji, M Baudry
Expert Opinion on Therapeutic Targets 2015
From UBE3A to Angelman syndrome: a substrate perspective
GL Sell, SS Margolis
Frontiers in neuroscience 2015
Neurodevelopmental disease: A molecular tightrope
Y Elgersma
Nature 2015
Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders
JM LaSalle, LT Reiter, SJ Chamberlain
Epigenomics 2015
Mitochondrial Superoxide Contributes to Hippocampal Synaptic Dysfunction and Memory Deficits in Angelman Syndrome Model Mice
E Santini, KL Turner, AB Ramaraj, MP Murphy, E Klann, H Kaphzan
The Journal of neuroscience : the official journal of the Society for Neuroscience 2015

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Blogged by 2
Posted by 7 X users
Referenced in 6 patents
On 5 Facebook pages
230 readers on Mendeley
See more details